glp-1 agonists for obesity What is the pipeline future medications for obesity? Frontiers | GLP−1 receptor agonists
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 6.Stidham R.W., Waljee A.K., Day N.M., Bergmans C.L., Zahn K.M., Higgins P.D., Wang S.C., Su G.L
2024, McIntyre, Roger S., et al
To do this merely manufacturing wont suffice
Altogether, clinical trials in phase 3 that applied semaglutide in monotherapy and combined with other antidiabetic drugs yielded similar results
doi: 10.1007/s00125-014-3171-6
